ARMS for EGFR mutation analysis of cytologic and corresponding lung adenocarcinoma histologic specimens

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 2, 2015, Pages 221-227

  Liu, Jinguo ^a   Zhao, Ruiying ^a   Zhang, Jie ^a   Zhang, Jian ^a  

^a SHANGHAI CHEST HOSPITAL   (China)

Author keywords

Adenocarcinoma; Cytology; Epidermal growth factor receptor; Lung cancer; Mutation analysis; Surgical pathology

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; DNA; EGFR PROTEIN, HUMAN;

ADULT; AGED; AMPLIFICATION REFRACTORY MUTATION SYSTEM; ANALYTIC METHOD; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; CYTOLOGY; EXON; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GENE MUTATION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; ADENOCARCINOMA; CANCER STAGING; CYTODIAGNOSIS; FOLLOW UP; GENETICS; LUNG TUMOR; MIDDLE AGED; MUTATION; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CYTODIAGNOSIS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES;

EID: 84921060365     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1807-z     Document Type: Article

References (27)

1. Aisner DL, Deshpande C, Baloch Z, Watt CD, Litzky LA, Malhotra B et al (2013) Evaluation of EGFR mutation status in cytology specimens: an institutional experience. Diagn Cytopathol 41:316–323
2. Boyle P, Levin B (2008) World cancer report 2008. International Agency for Research on Cancer, Lyon
3. Bruno P, Mariotta S, Ricci A, Duranti E, Scozzi D, Noto A et al (2011) Reliability of direct sequencing of EGFR: comparison between cytological and histological samples from the same patient. Anticancer Res 31:4207–4210
4. Chowdhuri SR, Xi L, Pham TH, Hanson J, Rodriguez-Canales J, Berman A et al (2012) EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection. Mod Pathol 25:548–555
5. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M et al (2007) Cancer incidence in five continents, vol IX. IARC Scientific Publications, Lyon
6. D’Angelo SP, Park B, Azzoli CG, Kris MG, Rusch V, Ladanyi M et al (2011a) Reflex testing of resected stage I through III lung adenocarcinomas for EGFR and KRAS mutation: report on initial experience and clinical utility at a single center. J Thorac Cardiovasc Surg 141:476–480
7. D’Angelo SP, Pietanza MC, Johnson ML, Riely GJ, Miller VA, Sima CS et al (2011b) Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas. J Clin Oncol 29:2066–2070
8. da Cunha Santos G, Saieg MA, Geddie W, Leighl N (2011) EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities. Cancer Cytopathol 119:80–91
9. Ellison G, Donald E, McWalter G, Knight L, Fletcher L, Sherwood J et al (2010) A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples. J Exp Clin Cancer Res 29:132
10. Girard N, Sima CS, Jackman DM, Sequist LV, Chen H, Yang JC et al (2012) Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma. Eur Respir J 39:366–372
11. Gupta R, Dastane AM, Forozan F, Riley-Portuguez A, Chung F, Lopategui J et al (2009) Evaluation of EGFR abnormalities in patients with pulmonary adenocarcinoma: the need to test neoplasms with more than one method. Mod Pathol 22:128–133
12. Han HS, Eom DW, Kim JH, Kim KH, Shin HM, An JY et al (2011) EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases. Clin Lung Cancer 12:380–386
13. Kalikaki A, Koutsopoulos A, Trypaki M, Souglakos J, Stathopoulos E, Georgoulias V et al (2008) Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC. Br J Cancer 99:923–929
14. Khode R, Larsen DA, Culbreath BC, Parrish S, Walker KL, Sayage-Rabie L et al (2013) Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas. Cancer Cytopathol 121:361–369
15. Kimura H, Kasahara K, Kawaishi M, Kunitoh H, Tamura T, Holloway B et al (2006) Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer. Clin Cancer Res 12:3915–3921
16. Ladanyi M, Pao W (2008) Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond. Mod Pathol 21:S16–S22
17. Malapelle U, de Rosa N, Rocco D, Bellevicine C, Crispino C, Illiano A et al (2012) EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study. J Clin Pathol 65:87–91
18. Navani N, Brown JM, Nankivell M, Woolhouse I, Harrison RN, Jeebun V et al (2012) Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients. Am J Respir Crit Care Med 185:1316–1322
19. Pao W, Ladanyi M (2007) Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method. Clin Cancer Res 13:4954–4955
20. Reinersman JM, Johnson ML, Riely GJ, Chitale DA, Nicastri AD, Soff GA et al (2011) Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans. J Thorac Oncol 6:28–31
21. Savic S, Tapia C, Grilli B, Rufle A, Bihl MP, de Vito Barascud A et al (2008) Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers. Br J Cancer 98:154–160
22. Shah PL, Singh S, Bower M, Livni N, Padley S, Nicholson AG (2006) The role of transbronchial fine needle aspiration in an integrated care pathway for the assessment of patients with suspected lung cancer. J Thorac Oncol 1:324–327
23. Smouse JH, Cibas ES, Janne PA, Joshi VA, Zou KH, Lindeman NI (2009) EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer. Cancer 117:67–72
24. Sun L, Zhang Q, Luan H, Zhan Z, Wang C, Sun B (2011) Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice. J Exp Clin Cancer Res 30:30
25. Sun PL, Jin Y, Kim H, Lee CT, Jheon S, Chung JH (2013) High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas. Cancer Cytopathol 121:311–319
26. Tanaka T, Nagai Y, Miyazawa H, Koyama N, Matsuoka S, Sutani A et al (2007) Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers. Cancer Sci 98:246–252
27. Yatabe Y, Matsuo K, Mitsudomi T (2011) Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma. J Clin Oncol 29:2972–2977